Is there a place for immunotherapy with interleukin-2 to prevent relapse after autologous stem cell transplantation for acute leukemia? [electronic resource]
Producer: 19950724Description: 397-405 p. digitalISSN:- 1042-8194
- Actuarial Analysis
- Acute Disease
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Clinical Trials as Topic
- Combined Modality Therapy
- Cytotoxicity, Immunologic -- drug effects
- Disease-Free Survival
- Humans
- Immunologic Factors -- therapeutic use
- Immunotherapy, Adoptive
- Interleukin-2 -- pharmacology
- Leukemia -- drug therapy
- Leukemia, Experimental -- therapy
- Neoplasm, Residual
- Rats
- Recombinant Proteins -- therapeutic use
- Remission Induction
- Transplantation Immunology
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.